YHB Investment Advisors Inc. Has $2.36 Million Stock Holdings in Align Technology, Inc. (NASDAQ:ALGN)

YHB Investment Advisors Inc. decreased its holdings in shares of Align Technology, Inc. (NASDAQ:ALGN) by 4.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 9,277 shares of the medical equipment provider’s stock after selling 444 shares during the quarter. YHB Investment Advisors Inc.’s holdings in Align Technology were worth $2,359,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Kayne Anderson Rudnick Investment Management LLC raised its holdings in Align Technology by 4,391.3% during the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 488,251 shares of the medical equipment provider’s stock valued at $117,879,000 after buying an additional 477,380 shares in the last quarter. Swedbank AB acquired a new position in shares of Align Technology during the 1st quarter valued at about $96,117,000. Bares Capital Management Inc. raised its stake in shares of Align Technology by 44.4% in the 1st quarter. Bares Capital Management Inc. now owns 819,930 shares of the medical equipment provider’s stock valued at $268,871,000 after acquiring an additional 252,220 shares in the last quarter. Point72 Asset Management L.P. lifted its holdings in Align Technology by 127.4% in the 2nd quarter. Point72 Asset Management L.P. now owns 343,512 shares of the medical equipment provider’s stock worth $82,934,000 after purchasing an additional 192,474 shares during the last quarter. Finally, Jacobs Levy Equity Management Inc. boosted its position in Align Technology by 371.0% during the first quarter. Jacobs Levy Equity Management Inc. now owns 218,779 shares of the medical equipment provider’s stock worth $71,742,000 after purchasing an additional 172,330 shares during the period. Institutional investors own 88.43% of the company’s stock.

Insider Activity at Align Technology

In other Align Technology news, Director C Raymond Larkin, Jr. purchased 6,500 shares of the business’s stock in a transaction on Thursday, August 15th. The stock was purchased at an average price of $235.33 per share, for a total transaction of $1,529,645.00. Following the completion of the purchase, the director now directly owns 28,247 shares in the company, valued at approximately $6,647,366.51. This trade represents a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.62% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of research firms have recently commented on ALGN. Evercore ISI dropped their price target on shares of Align Technology from $280.00 to $270.00 and set an “outperform” rating on the stock in a research report on Tuesday, October 8th. Needham & Company LLC started coverage on Align Technology in a research report on Thursday, October 10th. They issued a “hold” rating on the stock. Robert W. Baird cut their price objective on Align Technology from $370.00 to $325.00 and set an “outperform” rating for the company in a research report on Monday, July 22nd. Piper Sandler lowered their target price on Align Technology from $315.00 to $285.00 and set an “overweight” rating on the stock in a report on Thursday, October 17th. Finally, StockNews.com upgraded Align Technology from a “hold” rating to a “buy” rating in a report on Thursday, September 19th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, Align Technology presently has an average rating of “Hold” and a consensus price target of $291.25.

Align Technology Trading Down 1.5 %

Shares of NASDAQ:ALGN opened at $207.66 on Thursday. The business’s 50 day moving average is $234.20 and its 200-day moving average is $250.96. The firm has a market capitalization of $15.63 billion, a PE ratio of 34.21, a PEG ratio of 5.33 and a beta of 1.64. Align Technology, Inc. has a 1-year low of $176.34 and a 1-year high of $335.40.

Align Technology (NASDAQ:ALGN) last announced its quarterly earnings results on Wednesday, July 24th. The medical equipment provider reported $2.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.32 by $0.09. The firm had revenue of $1.03 billion for the quarter, compared to analyst estimates of $1.04 billion. Align Technology had a net margin of 11.34% and a return on equity of 14.07%. The business’s revenue for the quarter was up 2.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.73 EPS. On average, sell-side analysts predict that Align Technology, Inc. will post 7.61 EPS for the current year.

Align Technology Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.